- Home
- BKE vs IDYA Comparison
BKE vs IDYA Comparison
Compare BKE & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKE | IDYA |
|---|---|---|
| Founded | 1948 | 2015 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 1992 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BKE | IDYA |
|---|---|---|
| Price | $55.41 | $37.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $55.00 | $49.33 |
| AVG Volume (30 Days) | 542.1K | ★ 940.1K |
| Earning Date | 11-21-2025 | 02-12-2026 |
| Dividend Yield | ★ 7.92% | N/A |
| EPS Growth | ★ 3.79 | N/A |
| EPS | ★ 4.09 | N/A |
| Revenue | ★ $1,277,894,000.00 | $214,834,000.00 |
| Revenue This Year | $7.75 | $2,662.86 |
| Revenue Next Year | $2.59 | N/A |
| P/E Ratio | $13.59 | ★ N/A |
| Revenue Growth | 4.67 | ★ 5377.66 |
| 52 Week Low | $33.12 | $13.45 |
| 52 Week High | $61.69 | $39.28 |
Technical Indicators
Market Signals| Indicator | BKE | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 62.33 |
| Support Level | $53.49 | $35.94 |
| Resistance Level | $55.95 | $39.28 |
| Average True Range (ATR) | 1.37 | 1.44 |
| MACD | 0.09 | 0.20 |
| Stochastic Oscillator | 53.95 | 72.42 |
Price Performance
Historical ComparisonAbout BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.